Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm [Phase 1, Phase 2]

View source ↗

Summary

This update reports on a randomized, double-blind, placebo-controlled Phase 1/2 trial evaluating simvastatin for subarachnoid hemorrhage-induced vasospasm; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vasospasm
• Subarachnoid Hemorrhage

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Subarachnoid Hemorrhage, Delayed Vasospasm | Phase 1, Phase 2 | Status: COMPLETED